AU2001254924A1 - Powders for use in a dry powder inhaler - Google Patents

Powders for use in a dry powder inhaler

Info

Publication number
AU2001254924A1
AU2001254924A1 AU2001254924A AU5492401A AU2001254924A1 AU 2001254924 A1 AU2001254924 A1 AU 2001254924A1 AU 2001254924 A AU2001254924 A AU 2001254924A AU 5492401 A AU5492401 A AU 5492401A AU 2001254924 A1 AU2001254924 A1 AU 2001254924A1
Authority
AU
Australia
Prior art keywords
powders
dry powder
powder inhaler
inhaler
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001254924A
Inventor
David Ganderton
Brian John Meakin
David Alexander Vodden Morton
John Nicholas Staniforth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectura Ltd
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of AU2001254924A1 publication Critical patent/AU2001254924A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
AU2001254924A 2000-05-03 2001-05-03 Powders for use in a dry powder inhaler Abandoned AU2001254924A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0010709.4A GB0010709D0 (en) 2000-05-03 2000-05-03 Powders for use a in dry powder inhaler
GB0010709 2000-05-03
PCT/GB2001/001942 WO2001082906A1 (en) 2000-05-03 2001-05-03 Powders for use in a dry powder inhaler

Publications (1)

Publication Number Publication Date
AU2001254924A1 true AU2001254924A1 (en) 2001-11-12

Family

ID=9890912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001254924A Abandoned AU2001254924A1 (en) 2000-05-03 2001-05-03 Powders for use in a dry powder inhaler

Country Status (5)

Country Link
US (1) US20030186843A1 (en)
EP (1) EP1278516A1 (en)
AU (1) AU2001254924A1 (en)
GB (1) GB0010709D0 (en)
WO (1) WO2001082906A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP1500390B1 (en) 2003-07-25 2005-08-17 Ferring B.V. Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
JP5087182B1 (en) * 2012-06-13 2012-11-28 クリニプロ株式会社 Method for producing inhalable powder
EP2879531B1 (en) * 2012-08-02 2020-09-02 Philip Morris Products S.a.s. Smoking article with menthol filter
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US10149823B2 (en) 2013-04-30 2018-12-11 Otitopic Inc. Dry powder formulations and methods of use
WO2015127315A1 (en) 2014-02-20 2015-08-27 Otitopic Inc. Dry powder formulations for inhalation
SG11201607705XA (en) 2014-03-19 2016-10-28 Infinity Pharmaceuticals Inc Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
JP6672258B2 (en) * 2014-04-08 2020-03-25 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Nicotine preparation and method for producing the same
WO2015179369A1 (en) 2014-05-20 2015-11-26 Infinity Pharmaceuticals, Inc. Treatment of pulmonary or respiratory diseases by inhalation administration of pi3 kinase inhibitors
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
US20170071248A1 (en) * 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
JP2021502954A (en) 2017-09-22 2021-02-04 オティトピック インク． Dry powder composition containing magnesium stearate
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
US10785998B2 (en) * 2017-10-25 2020-09-29 Michael Overmyer Method of using a cleaning, disinfecting and lubricating composition for a dental unit or beer fluid encompassing system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2131285C (en) * 1992-03-10 2004-06-29 Lewis James Baskeyfield Pharmaceutical inhalation compositions
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
HUT75676A (en) * 1994-03-07 1997-05-28 Inhale Therapeutic Syst Methods and compositions for pulmonary delivery of insulin
US6192882B1 (en) * 1997-02-24 2001-02-27 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
EP0896821B1 (en) * 1997-08-08 2003-06-04 Rotta Research Laboratorium S.P.A. A novel pharmaceutical composition for inhalation containing CR 2039 (andolast)

Also Published As

Publication number Publication date
US20030186843A1 (en) 2003-10-02
WO2001082906A1 (en) 2001-11-08
EP1278516A1 (en) 2003-01-29
GB0010709D0 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
AU2001233201A1 (en) Dry powder inhaler
SI1294421T1 (en) Dry Powder Inhaler
AU9043201A (en) Continuous dry powder inhaler
AU2001254924A1 (en) Powders for use in a dry powder inhaler
AU1409801A (en) Powder inhaler
IL149984A0 (en) Novel tiotropium-containing inhalation powder
AU2003220288A1 (en) Dry powder inhaler
AU2001257034A1 (en) Compressed gas dry powder inhaler
IL162858A0 (en) Dry powder inhaler
AU1037201A (en) Mechanical doses counter in a powder inhaler
AU2038300A (en) Inhalation powders
AU2001243611A1 (en) Stabilized dry powder formulations
AU2002223178A1 (en) Easy open end and can for powders
GB0003935D0 (en) Formulation for dry powder inhaler
AU4417101A (en) Metered dose inhaler
AU2001256168A1 (en) Metered dose inhaler
AU1912501A (en) Water-soluble powders for oral solution and use thereof
AU4831801A (en) Metered dose inhaler
EP1186253A4 (en) Powder puff
AU2001279771A1 (en) Carrier material for dry powder inhalation
AU1752601A (en) Dry powder inhaler
AU4417001A (en) Metered dose inhaler
AU2001249479A1 (en) Physically stabilized dry powder formulations
AU2001241697A1 (en) Dosing system for a dry powder inhaler
AU2001229334A1 (en) Device for dry powder inhalation